Fundraising FoxTelegraph Hill Partners — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.
BiotechDigital HealthMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inThomas Raffin(Director)in
Board seatRobert Shepler· per SEC Form D
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
Board seatRobert Shepler· per SEC Form D
Co-investors5AM VenturesArboretum VenturesF-Prime CapitalHealthQuest CapitalSofinnova Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.